Home > Press > Sunshine Bio Investments World Launches Funding Initiatives in Multi-Billion Dollar North American Markets Serving Stem Cell Research, Genomics, Prote
Abstract:
Sunshine Bio Investments World, a privately held Canadian company (www.sunshinebioworld.com), has established U.S. headquarters in Miami and initiated venture funding for a variety of biotech, pharmaceutical and medical device companies active in the multi-billion dollar North American biotech environment.
Miami operations are located at 5600 Collins Avenue, Suite 17C, Miami, Florida, 33140. Telephone is 305-433-2121.
According to Michael Di Turi, Sunshine Bio Investments World President and CEO, "Most investment banks in the North American markets do not closely follow small and mid-cap biotech and biodefense sectors. At the same time, many analysts are not adequately qualified to fairly and thoroughly evaluate the potential of these companies.
"Pharmagenomics, nanomedicine and regenerative medicine will predict, prevent and cure life-threatening viruses and diseases," continued Mr. Di Turi. "Sunshine Bio Investments World partners are at the forefront of 21st century technologies. We are seeking partners and alliances to develop, market and distribute products and solutions to improve the health, safety and security of individuals worldwide," he said.
Sunshine Bio Investments World Companies Are Already Making Breakthroughs, Contributing to Respective Industries
Mr. Di Turi added, "Companies we are presently funding are located across Canada, California and Florida, contributing to industry knowledge, and making significant scientific breakthroughs. Areas of expertise include commercialization of drug-based therapies to treat central nervous system diseases, programs to repair neurological function lost due to disease or injury, single-walled carbon nanotubes, nanomaterials and other advanced materials for high value-added applications; and clinically proven procedures available for the cryogenic storage of umbilical cord blood (UCB)."
####
For more information, please click here
Contacts:
Tony Sciangula
Sunshine Bio Investments World
786-704-4509
or
Steven Swartz
SIZZLE PR
978-524-9595
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Flexible electronics integrated with paper-thin structure for use in space January 17th, 2025
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Openings/New facilities/Groundbreaking/Expansion
OCSiAl expands its graphene nanotube production capacities to Europe June 17th, 2022
GLOBALFOUNDRIES Moves Corporate Headquarters to its Most Advanced Semiconductor Manufacturing Facility in New York April 27th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
The National Space Society Congratulates SpaceX on Starship’s 7th Test Flight: Latest Test of the Megarocket Hoped to Demonstrate a Number of New Technologies and Systems January 17th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |